The Next Wave in Meditation Research Will Look to Advanced Practitioners for Insights
Advanced meditation and related experiences offer new possibilities for improving mental health and well-being.
Contact Information
1 Bowdoin Square, 6th Floor
Boston,
MA
02114
Phone: 617-726-8895
How to Make an Appointment
Call 617-726-8895 and select option 4 for an initial phone screen to determine whether this program is appropriate for you.
Because of high demand for our clinicians, treatment studies can provide an excellent option for prospective patients. If your case is appropriate, you will be matched to a provider based on your insurance and our provider availability.
For information on participating in a research study, call 877-552-5837.
The clinical component of the Depression Clinical and Research Program (DCRP) delivers care outside of the research setting to people with depressive disorders. The program provides a number of different services, including:
The DCRP staff includes full-time psychiatrists, psychologists, research fellows, along with research coordinators, a program coordinator, a data analyst, a practice manager and a patient service coordinator.
This program is designed to help young people—men and women (ages 14 to 30)—increase their resilience and develop better coping skills for managing stress.
Learn more about the Resilience Program
The program does not accept all insurances, and the individual physicians vary in what insurance they accept. If your insurance is not accepted by the program, you may elect to self-pay if your insurance allows it. Medicare, MassHealth products, Health Safety Net, Harvard Pilgrim, United Health Care and some Tufts Health plans that subcontract (carve out) their mental health benefits do not allow this option. The program does not accept the Magellan carve-out.
The DCRP conducts leading-edge research in the area of depression, with a focus on testing novel antidepressant treatments and developing new tools to understand the biological changes that occur in this condition. Our program is a leader worldwide in the study of unipolar depressive disorders. The DCRP’s research has informed clinical practice and contributed to the development of new standards of care for depression. DCRP researchers have received significant funding from both the National Institute of Mental Health and industry sponsors.
If any of these studies interest you, please call us at 877-552-5837 to learn more. All inquiries will be kept confidential.
The Depression Clinical and Research Program conducts ground-breaking studies in neuroscience, genetics, and the assessment of new and established treatments for mental health disorders. We are lead by a team of depression specialists.
To learn more about the nature and treatment of depression, we suggest the following websites:
Depression can profoundly impact an individual's quality of life. Its impact on well-being is comparable to or greater than many chronic medical conditions. Depression is currently the leading cause of disability in developed countries and the fourth leading cause of disability worldwide. Projections estimate that depression will be the second leading cause of disability worldwide by 2020. The annual cost of depression in the U.S. alone is approximately $70-80 billion.
Depression has also been characterized by an increased risk of suicide, particularly in children and adolescents. In the last 50 years, the suicide rate has tripled for 15-19-year-olds and doubled for 10-14-year-olds. Currently, suicide ranks as the third leading cause of death in adolescents.
Each year, thousands of individuals struggling with depression will turn to the Depression Clinical and Research Program (DCRP) at Massachusetts General Hospital for therapies that offer hope and alleviate suffering. The DCRP relies on philanthropy to advance its mission of providing the highest-quality patient care and conducting state-of the-art scientific research to discover more effective and innovative depression therapies. Thanks to the generosity of individuals, foundations and private and public supporters, the DCRP remains passionately committed to generating new treatments and standards of care – not only for our patients, but also for the millions of people worldwide who suffer from this disorder. Philanthropy enables the DCRP to:
The DCRP is poised to make a profound impact on depression treatment, while also fostering a vital training ground for the next generation of leaders in the field.
For 80 years, Mass General's Psychiatry Department has provided the highest quality patient care through pioneering research.
We provide care for patients of any age throughout the lifespan.
Resources for patients and families including educational programs and information about mental health issues from the Department of Psychiatry.
Advanced meditation and related experiences offer new possibilities for improving mental health and well-being.
Heated yoga sessions led to reduced depressive symptoms in adults with moderate-to-severe depression.
Get information about the importance of screening for depression and talking to your primary care provider (PCP) if you think you might be suffering from depression.
Results indicate a link between reduced mobility during the pandemic and greater risk for depressive symptoms.
Karmel Choi, PhD, and Jordan Smoller, MD, ScD, from the Mass General Department of Psychiatry and colleagues recently published an article in Nature Mental Health, titled Social Support and Depression During a Global Crisis.
Managing Anxiety: A Handout for Families of Children with Food Allergies
The integration of patient care and clinical research has been a hallmark of the Department of Psychiatry for more than 30 years. Today, the department has the largest clinical research program in the hospital, with studies at the forefront of neuroscience, molecular biology and genetics.